Cambio - Excellence in Molecular Biology

<b>New </b> - Biopharma Quality Control

New - Biopharma Quality Control : Regulatory Mycoplasma Testing

Regulatory Mycoplasma Testing

Detection of mycoplasma contamination in cell culture and cell culture derived products with Venor®GeM mycoplasma detection kits.

 

  • Ready-to-use lyophilized kit components simplify logistics and storage
  • Easy-to-use protocol
  • Different versions for conventional PCR, real-time PCR or digital PCR*
  • Validated according to EP 2.6.7, JP G3, USP <63> and USP <1071>
  • TaqMan® probes ensure the highest level of PCR specificity
  • Detect > 100 mycoplasma species
  • Lyophilized, non-infectious mycoplasma sensitivity standards, each containing 10 or 100 CFU of the chosen Mycoplasma species

Mycoplasma, being the smallest known self-replicating bacteria, are capable of infecting a wide range of cell cultures used in the production of biopharmaceuticals, thus posing a significant threat to the safety and efficacy of biopharmaceutical products.

The implementation of robust mycoplasma testing protocols is essential to ensure the safety and quality of biopharmaceutical products. Early detection and mitigation of mycoplasma contamination can prevent costly production delays, product recalls, and potential harm to patients. Therefore, biopharmaceutical manufacturers must employ validated mycoplasma testing methods as part of their quality control procedures. PCR-based methods have become the preferred choice for mycoplasma testing due to their high sensitivity, specificity, and rapid time-to-result.

Minerva Biolabs has developed several mycoplasma detection kits that are specially designed for institutions and companies involved in testing mycoplasma contamination according to EP 2.6.7, USP <63> and JP G3.

The kits enable rapid and reliable identification of mycoplasma in cell culture and cell culture derived biologicals, like ATMPs. All Mollicutes (Mycoplasma, Acholeplasma, Spiroplasma) species so far described as contaminants of cell cultures and media components are specifically detected by amplification of a highly conserved rRNA operon, or more specifically, the 16S rRNA coding region in the mycoplasma genome.

Explore our innovative, robust and highly sensitive mycoplasma detection kits for conventional PCR, real-time PCR or digital PCR* that has been effectively validated according to EP 2.6.7, USP <63> and JP G3.

(* according products will be released soon. Subscribe to our newsletter to get notified.)

Dowload our flyer for product feature comparison.

"Which kit to choose?"

 

Mycoplasma Standards 100GC®

100GC® Mycoplasma Standards are non-infectious reference materials for matrix-specific validation of PCR-based mycoplasma tests

Minerva Biolabs

Catalogue No.DescriptionPack SizePriceQty
104-1001100GC® Mycoplasma StandardMycoplasma arginini Standard £355.00 Quantity Add to Order
104-2001100GC® Mycoplasma StandardMycoplasma orale Standard £355.00 Quantity Add to Order
104-2001100GC® Mycoplasma StandardMycoplasma orale Standard £355.00 Quantity Add to Order
104-2001100GC® Mycoplasma StandardMycoplasma orale Standard £355.00 Quantity Add to Order
104-2001100GC® Mycoplasma StandardMycoplasma orale Standard £355.00 Quantity Add to Order
104-2001100GC® Mycoplasma StandardMycoplasma orale Standard £355.00 Quantity Add to Order
104-2001100GC® Mycoplasma StandardMycoplasma orale Standard £355.00 Quantity Add to Order
104-2001100GC® Mycoplasma StandardMycoplasma orale Standard £355.00 Quantity Add to Order
104-9001100GC® Mycoplasma StandardMycoplasma citri Standard £355.00 Quantity Add to Order
104-9001100GC® Mycoplasma StandardMycoplasma citri Standard £355.00 Quantity Add to Order

Description

100GC® Mycoplasma Standards are non-infectious reference materials for matrix-specific validation of PCR-based mycoplasma tests.
- Compliant with EP 2.6.7 (12.2)
- Ready-to-use 100 GC/ml standards for reliable matrix-specific validation
- Non-infectious and regulatory safe

Mycoplasmas represent one of the greatest contamination risks in cell cultures and in biopharmaceutical production (e.g. ATMPs). European Pharmacopoeia (EP) 2.6.7 requires a validated test method for the release of such products, capable of detecting both culturable and non-culturable mycoplasmas. Nucleic acid amplification techniques (NAT) have become the new gold standard, as they reliably detect both forms. The previously applied sensitivity limit of 10 CFU/ml was based on classical culture methods.

With the new edition 12.2 of EP 2.6.7, the requirements change: For PCR methods, a sensitivity limit of less than 100 genome copies/ml (GC/ml) is introduced. This PCR-appropriate unit is considered practical for PCR laboratories and has long been expected as a standard for determining the detection limit.

Our 100GC® Mycoplasma Standards are specifically designed to meet these new requirements. They are non-infectious and therefore safe to handle, titrated to 100 GC, and comply with the new regulatory guideline for NAT standards. The standards are lyophilized and ready to use after reconstitution. In addition, the standards can be used as an external positive control with defined concentration, fulfilling all new regulatory requirements.

Optionally, 10 CFU/ml standards remain available for comparability with classical culture methods.

Application Mycoplasma detection
Use cases
  • Method validation according to EP 2.6.7
  • External positive control for mycoplasma testing
  • QC batch release and routine testing
Contents
  • 3 vials each containing 100 GC (lyophilized)
  • 1 vial PCR-grade water
Detection method
  • PCR
  • real-time PCR (qPCR)
  • digital PCR (dPCR/ddPCR™)
Compliance EP 2.6.7
Required equipment
& consumables
  • PCR thermal cycler
  • PCR reaction tubes
  • Centrifuge for 1.5 mL PCR tubes
  • Pipettes
  • Mycoplasma detection kit
Concentration after
reconstitution
100 GC/ml
Sample type RNA-containing DNA standard
Storage 2-8 °C
Shipping Ambient temperature
Shelf life See expiration date on package

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200